1-202012678-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_004433.5(ELF3):c.517G>A(p.Gly173Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000336 in 1,609,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_004433.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELF3 | NM_004433.5 | c.517G>A | p.Gly173Ser | missense_variant | 5/9 | ENST00000367284.10 | NP_004424.3 | |
ELF3 | NM_001114309.2 | c.517G>A | p.Gly173Ser | missense_variant | 5/9 | NP_001107781.1 | ||
ELF3 | XM_005244942.4 | c.517G>A | p.Gly173Ser | missense_variant | 5/6 | XP_005244999.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELF3 | ENST00000367284.10 | c.517G>A | p.Gly173Ser | missense_variant | 5/9 | 1 | NM_004433.5 | ENSP00000356253 | P1 | |
ENST00000504773.1 | n.215+1094G>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000493 AC: 12AN: 243260Hom.: 0 AF XY: 0.0000378 AC XY: 5AN XY: 132182
GnomAD4 exome AF: 0.0000350 AC: 51AN: 1456910Hom.: 0 Cov.: 33 AF XY: 0.0000386 AC XY: 28AN XY: 724506
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74334
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at